Department: Molecular Biosciences
This Major shares core requirements with the Cancer Biology, Ph.D. ; Cancer Chemical Biology, Ph.D. ; and Integrated Mathematical Oncology, Ph.D.
The Cancer Immunology and Immunotherapy major consists of focused training in tumor immunology and cancer immunotherapy. Students will also receive interdisciplinary training in the broader field of cancer biology through coursework and immersion in the Moffitt Cancer Center’s research endeavors. The study of tumor immunology has led to major advances in the understanding of how tumors evade the immune system, resulting in multiple new immunotherapeutic modalities approved by the FDA for the treatment of cancer patients. Students will have the opportunity to conduct innovative research at the molecular and cellular level to reveal opportunities to alter the course of tumor progression.
This Major will provide students a unique foundation of knowledge and practical experience in the rapidly advancing arena of cancer immunotherapy. Students will also train alongside individuals studying other areas of cancer biology, providing a broad base of understanding of cancer and increasing the potential for interdisciplinary research. Graduates of this major will be positioned to enter the technological workforce ready to discover and implement immunological advances that will have a key impact on cancer patient therapy.
The Major is a joint endeavor between the Moffitt Cancer Center and the University of South Florida. Moffitt Cancer Center is located on the campus of the University of South Florida and is a leading institution of basic research, clinical research, and patient treatment with a focused mission “to contribute to the prevention and cure of cancer.” The Moffitt Cancer Center is officially designated as a Comprehensive Cancer Center by the National Cancer Institute of the National Institutes of Health.
Major Research Areas
- Research drives discoveries in cancer immunology through basic and translational research in five areas:
- Tumor Immune Microenvironment (innate and adaptive regulatory mechanisms)
- Immune Regulation in Cancer (metabolism, T cell checkpoints)
- Vaccine-Based Therapies (Dendritic Cells, intralesional therapies)
- Adoptive T Cell Therapy (TIL, CAR)
- Hematological Diseases (MDS, graft-vs-host)
Must meet University Admission and English Proficiency requirements, as well as requirements for admission to the major, listed below.
- Extensive background in field of biology, immunology, or chemistry
- GRE optional
- Advanced coursework and research experience preferred
All Cancer Immunology and Immunotherapy Ph.D. students in good standing will receive a highly competitive stipend. All students also receive student health insurance coverage and direct payment in full of all required tuition and required fees. Please visit the Program’s website for current stipend levels.